NJ A1439 | 2024-2025 | Regular Session
Note: Carry Over of previous A553
Note: Carry Over of previous S301
Note: Carry Over of previous S301
Status
Spectrum: Partisan Bill (Democrat 8-0)
Status: Introduced on January 9 2024 - 25% progression
Action: 2024-01-09 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 9 2024 - 25% progression
Action: 2024-01-09 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.
Title
Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-01-09 | Assembly | Introduced, Referred to Assembly Financial Institutions and Insurance Committee |
Same As/Similar To
A553 (Carry Over) 2022-01-11 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
S301 (Carry Over) 2022-01-11 - Introduced in the Senate, Referred to Senate Commerce Committee
S301 (Carry Over) 2022-01-11 - Introduced in the Senate, Referred to Senate Commerce Committee
Subjects
New Jersey State Sources
| Type | Source |
|---|---|
| Summary | https://www.njleg.state.nj.us/bill-search/2024/A1439 |
| Text | https://pub.njleg.gov/Bills/2024/A1500/1439_I1.HTM |
